Biggest News Aggregation in the World
📰 Section Chief News

Page 23 - Section Chief News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Section Chief. Real-time updates on events, politics, business and more.

Book review: Conveying the atrocious

Unlike Transitions in Taiwan, the previous White Terror-themed collection from Cambria, this latest anthology addresses Chinese Nationalist Party (KMT) crimes head on. In Wu Chuo-liu’s (吳濁流) almost novella-length “Potsdam Section Chief,” for example, the depiction of protagonist Fan Hanzhi’s wanton venality is unvarnished. He is shown as a traitor, informer, thief and racketeer. Lest the reader be left with the impression that Fan is an aberration, a lone wolf operating within an ...
Hsin Pei Shih Yilan Xian Wu Chuo Liu Sylvia Li Chun Lin Darryl Sterk Lu Heruo

Detroit Leadership

Orville O. Greene was appointed as Special Agent in Charge of the Detroit Field Division of the Drug Enforcement Administration (DEA) April 27, 2022.  As the Special Agent in Charge, Mr. Greene is responsible for all DEA operations throughout Michigan, Ohio and northern Kentucky.  Mr. Greene previously served as Assistant Special Agent in Charge of the Washington Field Division, Baltimore District Office from February 2020 to June 2022.  During his tenure in Baltimore, Mr. Greene served as th...
New York United States John Jay College Of Criminal Justice Orvilleo Greene Operations Division Crime Drug Enforcement Task Force Commander
Source: dea.gov

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis five-year Kymriah® data show durable remission and long-term survival maintained in children and young adults with advanced B-cell ALL

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis five-year Kymriah® data show durable remission and long-term survival maintained in children and young adults with advanced B-cell ALL
United States University Of Pennsylvania East Hanover Isabella Zinck Jeff Legos Stephan Grupp

Novartis Pharma AG: Novartis five-year Kymriah data show durable remission and long-term survival maintained in children and young adults with advanced B-cell ALL

In final ELIANA analysis, 55% of patients with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) who were treated with CAR-T cell therapy Kymriah were still alive after five years1 Nearly
United States University Of Pennsylvania East Hanover Isabella Zinck Jeff Legos Stephan Grupp

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science